Selective vertical transmission of HIV-1 antiretroviral resistance mutations

被引:77
作者
Colgrove, RC
Pitt, J
Chung, PH
Welles, SL
Japour, AJ
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[2] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA
[4] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
关键词
zidovudine; vertical transmission; drug resistance;
D O I
10.1097/00002030-199817000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine the patterns of vertical transmission of zidovudine (ZDV) resistance mutations. Design: HIV-1 reverse transcriptase codons 10-250 were sequenced from 24 pairs of ZDV-exposed women and their HIV-infected infants as part of the Women and Infants Transmission Study. Methods: Viral RNA was extracted from tissue culture supernatants and sequenced using fluorescent dye-primer chemistry and an automated sequencer. Results: For 17 of these pairs, maternal and infant sequences were identical to one another and lacking known ZDV resistance mutations. The remaining seven maternal sequences contained known mutations associated with ZDV resistance at reverse transcriptase codons 70, 210, 215 and 219. In each case where the maternal HIV isolate showed a pure mutant species, the infant sequence was identical. When the maternal sequence showed the presence of a sequence mixture at codon 70 or 219, the infant's virus showed only wild-type sequence even when the ZDV-resistant mutant was quantitatively dominant in the mother. The single maternal HIV isolate showing mixed sequence at codon positions 210 and 215 transmitted an unmixed mutant to the infant at both positions. When maternal mixtures were present at sites not associated with ZDV resistance, only the dominant species appeared in the infant. Conclusions: When maternal HIV isolates contained mixed wild-type and ZDV-resistant subpopulations, only a single component of the mixture could be detected in the infected infants. Resistance mutants without the codon 215 mutation were not transmitted from mixtures, even when the mutants formed the majority of circulating maternal virus. In perinatal HIV transmission, specific ZDV-resistant HIV genotypes circulating in the maternal virus pool may influence whether infection in the infant will be established by a wild-type or ZDV-resistant HIV strain. (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:2281 / 2288
页数:8
相关论文
共 29 条
[1]   Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription [J].
Arts, EJ ;
Wainberg, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :527-540
[2]   HIV-1: Gambling on the evolution of drug resistance? [J].
Brown, AJL ;
Richman, DD .
NATURE MEDICINE, 1997, 3 (03) :268-271
[3]  
Coffin JM, 1996, AIDS, V10, pS75
[4]  
COLGROVE R, 1997, 4 C RETR OPP INF WAS
[5]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[6]   HIV-1 DRUG-RESISTANCE - MOLECULAR PATHOGENESIS AND LABORATORY MONITORING [J].
DAQUILA, RT .
CLINICS IN LABORATORY MEDICINE, 1994, 14 (02) :393-422
[7]   ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY [J].
DAQUILA, RT ;
JOHNSON, VA ;
WELLES, SL ;
JAPOUR, AJ ;
KURITZKES, DR ;
DEGRUTTOLA, V ;
REICHELDERFER, PS ;
COOMBS, RW ;
CRUMPACKER, CS ;
KAHN, JO ;
RICHMAN, DD .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) :401-408
[8]   Structural mechanisms of HIV drug resistance [J].
Erickson, JW ;
Burt, SK .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :545-571
[9]  
HAHN BH, 1989, HIV DETECTION GENETI, P257
[10]  
Ho DD, 1995, J BIOL REG HOMEOS AG, V9, P76